Suchergebnisse - "Smith, Ian"

PubPharm (53)

1

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

enthalten in: Nature communications | 2023

von Schuster, E. | Lopez-Knowles, E. | Alataki, A. | +12

2

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer : a multi-operator and multi-institutional study

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022

von Acs, B. | Leung, S. | Kidwell, K. | +120

3

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition : a POETIC study

enthalten in: Breast cancer research : BCR | 2022

von Lopez-Knowles, E. | Detre, S. | Hills, M. | +11

4

Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer : a single institution experience

enthalten in: Breast cancer research and treatment | 2022

von Okines, A. | Irfan, T. | Asare, B. | +8

5

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Bergamino, M. | Morani, G. | Parker, J. | +9

6

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

enthalten in: EBioMedicine | 2022

von Bergamino, M. | López-Knowles, E. | Morani, G. | +114

7

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative : ASCO Guideline Update

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Moy, B. | Rumble, R. | Come, S. | +21

8

Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer

enthalten in: Breast cancer research and treatment | 2021

von Haynes, B. | Schuster, G. | Buus, R. | +20

9

Assessment of Ki67 in Breast Cancer : Updated Recommendations From the International Ki67 in Breast Cancer Working Group

enthalten in: Journal of the National Cancer Institute | 2021

von Nielsen, T. | Leung, S. | Rimm, D. | +19

10

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Johnston, S. | Harbeck, N. | Hegg, R. | +27

CommentIn: J Clin Oncol. 2020 Dec 1;38(34):3977-3979. - PMID 32954928

1
2
3
4
5
6
Nächster »
[6]